Benefits Among Patients With Alpha-1 Antitrypsin Deficiency Enrolled in a Disease Management and Prevention Program

Chronic Obstructive Pulmonary Diseases - United States
doi 10.15326/jcopdf.4.1.2016.0161
Full Text
Abstract

Available in full text

Date
Authors
Publisher

COPD Foundation

Related search

Alpha 1-Antitrypsin Deficiency and Liver Disease.

BMJ
1981English

Alpha-1 Antitrypsin Deficiency in Patients With Chronic Hepatitis

Turkish Journal of Gastroenterology
Gastroenterology
2012English

Alpha-1-Antitrypsin Deficiency

2020English

Alpha-1 Antitrypsin Deficiency

Journal of insurance medicine (New York, N.Y.)
Medicine
2015English

Safety and Efficacy of Alpha-1-Antitrypsin Augmentation Therapy in the Treatment of Patients With Alpha-1-Antitrypsin Deficiency

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Alpha‐1‐Antitrypsin Deficiency

English

Alpha 1-Antitrypsin Deficiency in Patients With Chronic Obstructive Pulmonary Disease Patients: Is Systematic Screening Necessary?

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2019English

Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease

Annals of the American Thoracic Society
PulmonaryRespiratory Medicine
2016English

Impact of a Health Management Program on Healthcare Outcomes Among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis

Advances in Therapy
MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy